Breaking News Instant updates and real-time market news.

EIGR

Eiger BioPharmaceuticals

$10.25

0.05 (0.49%)

16:35
10/15/18
10/15
16:35
10/15/18
16:35

683 Capital reports 5.9% passive stake in Eiger BioPharmaceuticals

  • 27

    Nov

EIGR Eiger BioPharmaceuticals
$10.25

0.05 (0.49%)

09/04/18
PIPR
09/04/18
NO CHANGE
Target $24
PIPR
Overweight
Eiger can file lonafarnib without additional studies, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff says feedback from the FDA will enable Eiger BioPharmaceuticals to file an investigational new drug application for lonafarnib to treat orphan indication Hutchinson-Gilford Progeria syndrome as soon as 2019. Importantly, this accelerates anticipated timelines because Eiger is not required to conduct additional clinical studies for approval, Tenthoff tells investors in a research note. He beieves that if approved, Eiger "could gain a valuable Pediatric Priority Review Voucher shared with the Progeria Research Foundation." The analyst reiterates an Overweight rating on the shares with a $24 price target.
08/27/18
JEFF
08/27/18
NO CHANGE
Target $25
JEFF
Buy
Jefferies sees good entry point for Eiger BioPharmaceuticals ahead of update
Jefferies analyst Maury Raycroft believes current Eiger BioPharmaceuticals share levels offer a good entry point ahead of news from the Phase III D-LIVR endpoints in hepatitis delta virus based on FDA feedback. The analyst does not anticipate major surprises around the update and expect the outcome to be viewed positively. The announcement should give the stock a bump and add momentum to a second half of 2018 run-up that will include several key catalysts, Raycroft tells investors in a research note. He sees little downside risk in Eiger shares and keeps a Buy rating on the name with a $25 price target.
05/30/18
PIPR
05/30/18
NO CHANGE
Target $24
PIPR
Overweight
Eiger BioPharmaceuticals price target lowered to $24 from $28 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff lowered his price target for Eiger BioPharmaceuticals to $24 to account for dilution from the recent financing. The analyst expects Phase II readouts for exendin in hypoglycemia and ubenimex in lymphedema in Q3. He reiterates an Overweight rating on the shares.
05/18/18
PIPR
05/18/18
NO CHANGE
Target $28
PIPR
Overweight
Eiger BioPharmaceuticals price target raised to $28 from $17 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Eiger BioPharmaceuticals (EIGR) to $28 after the company expanded its lonafarnib licensing agreement with Merck (MRK) for rights in ultra-orphan indication Hutchinson-Gilford Progeria syndrome. The analyst now anticipates FDA approval of lonafarnib in HGPS in 2020. He reiterates an Overweight rating on Eiger shares.

TODAY'S FREE FLY STORIES

HGV

Hilton Grand Vacations

$29.52

-0.09 (-0.30%)

16:33
11/19/18
11/19
16:33
11/19/18
16:33
Hot Stocks
Hilton Grand Vacations names Gordon Gurnik as COO »

Hilton Grand Vacations…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

LB

L Brands

$34.53

-0.75 (-2.13%)

16:33
11/19/18
11/19
16:33
11/19/18
16:33
Hot Stocks
Breaking Hot Stocks news story on L Brands »

L Brands reports Q3 SSS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

LB

L Brands

$34.53

-0.75 (-2.13%)

16:32
11/19/18
11/19
16:32
11/19/18
16:32
Hot Stocks
L Brands to cut annual dividend to $1.20 from $2.40 »

After extensive review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

T

AT&T

$30.34

0.04 (0.13%)

16:32
11/19/18
11/19
16:32
11/19/18
16:32
Periodicals
CNN abandons WH suit after Acosta's press pass restored, WP says »

CNN has withdrawn its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 03

    Dec

YUM

Yum! Brands

$88.15

-0.77 (-0.87%)

, TGT

Target

$77.77

-1.9 (-2.38%)

16:31
11/19/18
11/19
16:31
11/19/18
16:31
Hot Stocks
Yum! Brands names Brian Cornell as non-executive Chairman of Board »

Yum! Brands (YUM)…

YUM

Yum! Brands

$88.15

-0.77 (-0.87%)

TGT

Target

$77.77

-1.9 (-2.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 03

    Mar

LB

L Brands

$34.53

-0.75 (-2.13%)

16:31
11/19/18
11/19
16:31
11/19/18
16:31
Earnings
L Brands reports Q3 adjusted EPS 16c, consensus 15c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Earnings
Nuance sees FY19 EPS $1.02-$1.21, consensus $1.23 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Options
Preliminary option volume of 20.0M today »

Preliminary option volume…

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:30
11/19/18
11/19
16:30
11/19/18
16:30
Hot Stocks
Breaking Hot Stocks news story on Nuance 

Nuance trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NUAN

Nuance

$16.27

-0.61 (-3.61%)

16:28
11/19/18
11/19
16:28
11/19/18
16:28
Earnings
Nuance sees Q1 EPS 27c-29c, consensus 28c »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Limbach backs FY18 revenue view $530M-$550M, consensus $541.82M »

Backs FY18 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

PSTG

Pure Storage

$17.56

-1.56 (-8.16%)

16:27
11/19/18
11/19
16:27
11/19/18
16:27
Earnings
Pure Storage raises FY19 revenue view to $1.376B-$1.384B from $1.35B-$1.38B »

FY19 consensus $1.37B. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

LMB

Limbach Holding

$5.89

-0.17 (-2.81%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Earnings
Limbach reports Q3 EPS (46c) vs (12c) last year »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

EBS

Emergent BioSolutions

$69.73

-1.36 (-1.91%)

16:26
11/19/18
11/19
16:26
11/19/18
16:26
Hot Stocks
Emergent BioSolutions and VLAS report 'positive' trial results for Zika vaccine »

Emergent BioSolutions and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 12

    Dec

NVLN

Novelion Therapeutics

$1.00

0.0192 (1.96%)

16:25
11/19/18
11/19
16:25
11/19/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Novelion Therapeutics »

NB Public Equity reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTS

Akoustis

$4.55

-0.14 (-2.99%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
Hot Stocks
Akoustis announces first 5.2 HGz WiFi pre-production order »

Akoustis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 11

    Dec

  • 12

    Dec

AAPL

Apple

$185.80

-7.62 (-3.94%)

, FB

Facebook

$131.62

-7.93 (-5.68%)

16:24
11/19/18
11/19
16:24
11/19/18
16:24
OnTheFly
Fly Intel: Wall Street's top stories for Monday »

Stocks opened in negative…

AAPL

Apple

$185.80

-7.62 (-3.94%)

FB

Facebook

$131.62

-7.93 (-5.68%)

NSANY

Nissan

$0.00

(0.00%)

REN

Resolute Energy

$34.72

4.21 (13.80%)

XEC

Cimarex Energy

$88.03

-0.6 (-0.68%)

NIO

NIO Inc.

$7.81

0.63 (8.77%)

CFX

Colfax

$23.72

-4.285 (-15.30%)

BX

Blackstone

$31.78

-0.7 (-2.16%)

MDLZ

Mondelez

$44.45

0.17 (0.38%)

CPB

Campbell Soup

$38.47

-0.17 (-0.44%)

JD

JD.com

$21.09

-1.95 (-8.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 28

    Nov

  • 29

    Nov

  • 04

    Dec

DERM

Dermira

$9.73

0.04 (0.41%)

16:22
11/19/18
11/19
16:22
11/19/18
16:22
Upgrade
Dermira rating change  »

Dermira assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRI

Thomson Reuters

$48.42

-0.58 (-1.18%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Hot Stocks
Thomson Reuters receives shareholder approval for return of capital transaction »

Thomson Reuters announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 04

    Dec

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
11/19/18
11/19
16:20
11/19/18
16:20
Options
Closing CBOE SPX and VIX Index summary for November 19th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUS

Bellus Health

$0.00

(0.00%)

16:19
11/19/18
11/19
16:19
11/19/18
16:19
Conference/Events
Bellus Health to host conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORPN

Bio Blast Pharma

$1.19

-0.02 (-1.65%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Bio Blast Pharma to acquire Enlivex Therapeutics »

Bioblast Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCRH

QCR Holdings

$36.85

-0.34 (-0.91%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
QCR Holdings says Douglas Hultquist will retire as CEO, Helling to succeed »

QCR Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARAY

Accuray

$4.45

-0.27 (-5.72%)

, DHR

Danaher

$101.29

-1.95 (-1.89%)

16:18
11/19/18
11/19
16:18
11/19/18
16:18
Hot Stocks
Accuray names Shig Hamamatsu as CFO, effective immediately »

Accuray (ARAY) announced…

ARAY

Accuray

$4.45

-0.27 (-5.72%)

DHR

Danaher

$101.29

-1.95 (-1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 30

    Nov

  • 13

    Dec

JACK

Jack in the Box

$79.66

-0.97 (-1.20%)

16:17
11/19/18
11/19
16:17
11/19/18
16:17
Hot Stocks
Jack in the Box sees FY19 SSS flat to up 2%. »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.